Search for: "Generic Pharmaceutical Services, Inc."
Results 341 - 360
of 1,028
Sorted by Relevance
|
Sort by Date
8 May 2010, 6:53 pm
© 2010 Amaxx Risk Solutions, Inc. [read post]
2 Apr 2013, 10:33 am
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
10 Jun 2010, 6:15 am
©2010 Amaxx Risk Solutions, Inc. [read post]
24 Sep 2010, 1:22 pm
Patent No. 7,297,761 owned by Amylin Pharmaceuticals, Inc. and entitled PHARMACEUTICAL COMPOSITIONS CONTAINING EXENDINS. [read post]
10 Dec 2010, 2:54 pm
The following three cases were consolidated by the Court: Title: PLIVA, Inc. v. [read post]
6 Mar 2011, 10:04 am
©2011 Amaxx Risk Solutions, Inc. [read post]
24 Mar 2009, 5:22 am
Inc. [read post]
10 Dec 2019, 4:02 pm
Health care spending growth was mixed in 2018 for the three largest goods and service categories – hospital care, physician and clinical services, and retail prescription drugs. [read post]
10 Mar 2011, 7:58 am
The agency actually granted the approval to Massachusetts-based Hologic Inc., which presented the application and argued for the drug based on research by others. [read post]
8 Mar 2010, 4:36 pm
United States (Copyright Litigation Blog) (Property, intangible) US Trade Marks – Decisions Precedential No. 7: TTAB deems internet printouts admissible via notice of reliance: Safer, Inc v OMS Investments, Inc (TTABlog) TTAB vacates 2008 fraud ruling in Herbaceuticals, Inc v Xel Pharmaceuticals, Inc (TTABlog) TTAB affirms 2(d) refusal of CARMINE’S design for restaurant services in view of two other CARMINE’S designs: In… [read post]
8 Mar 2010, 4:36 pm
United States (Copyright Litigation Blog) (Property, intangible) US Trade Marks – Decisions Precedential No. 7: TTAB deems internet printouts admissible via notice of reliance: Safer, Inc v OMS Investments, Inc (TTABlog) TTAB vacates 2008 fraud ruling in Herbaceuticals, Inc v Xel Pharmaceuticals, Inc (TTABlog) TTAB affirms 2(d) refusal of CARMINE’S design for restaurant services in view of two other CARMINE’S designs: In… [read post]
13 Jan 2010, 3:00 am
Madras High Court decision in Novartis Glivec case (Patentcircle) Israel: State of Israel sues Omrix for NIS 500 million, claiming core technology is based on service inventions. [read post]
3 Sep 2014, 4:01 pm
Finally, SOLO IP reports that, for every 100 jobs in the legal services sector, 67 jobs are created outside the legal service sector -- so whose jobs are we creating? [read post]
26 Apr 2022, 3:48 pm
Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. [read post]
11 Jan 2022, 11:45 am
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
11 Jan 2022, 11:45 am
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
15 May 2020, 2:52 pm
The SEC charged two companies and a CEO with fraud: Applied BioSciences and Turbo Global Partners, Inc., and its CEO Robert W. [read post]
29 Aug 2014, 7:30 am
Readers may still be looking forward to a ruling from the Court of Justice of the European Union (CJEU) in Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, which was excitedly publicised by this Kat here and here on account of its potential for clarifying the scope of Bolar exemptions from patent infringement in favour of experimental use. [read post]
29 Jun 2011, 5:59 am
Prometheus Labs., Inc. [read post]
